ArticleJournal of hepatocellular carcinoma2025

MRI Radiomics to Predict Early Treatment Response to TACE Combined with Lenvatinib Plus a PD-1 Inhibitor for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Deyu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.